Stockreport

Novo Nordisk: Is The GLP-1 Golden Age Already Behind It? [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF NVO's latest GLP-1 drug delivered weaker weight loss than Eli Lilly's, clouding the outlook for the company's next wave of obesity drugs. Competition and drug pricing [Read more]